1 2
News & Information
PHEN Recognized During U. S. House Of Representatives Hearing

The U. S. House of Representatives Energy and Commerce Committee held a hearing on Wednesday, November 30th, "Examining the U. S. Preventive Services Task Force (USPSTF)."

PHEN Survivor Network News: Warriors In Action

PHEN is coming off the heels of one of our most successful and exciting events to date, the 12th Annual African American Prostate Cancer Disparity Summit! 

Racial Disparities Found in Prostate Cancer Treatment

African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.

Dementia Linked to Prostate Cancer ADT

Androgen deprivation therapy (ADT) for prostate cancer (PCa) is associated with an increased risk of dementia, according to a new study.

10-Year Mortality for Localized PCa Does Not Differ by Treatment Choice

Ten-year mortality rates of prostate cancer are low, regardless of whether patients are treated with radiotherapy, surgery, or undergo only active surveillance

Urinary, Sexual Function Recovery Differs by Localized PCa Treatment

Urinary, bowel, sexual function, and quality of life among men with prostate cancer may vary depending on treatment type.

Digital Rectal Examination, PSA Testing Rates Declining

HealthDay News) -- Following US Preventive Services Task Force (USPSTF) recommendations against routine prostate-specific antigen (PSA) screening..

 


Clinical Trials and African Americans Fight With Prostate Cancer
How clinical trials aid African Americans fight against prostate cancer. A Mediaplanet interview with Thomas Farrington
Partners